A Phase Ib/II Study of CYT997 in Combination With Carboplatin in Relapsed Glioblastoma Multiforme.

Trial Profile

A Phase Ib/II Study of CYT997 in Combination With Carboplatin in Relapsed Glioblastoma Multiforme.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Lexibulin (Primary) ; Carboplatin
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 23 Sep 2011 Status changed from active, no longer recruiting to completed, as reported in a YM BioSciences media release.
    • 23 Sep 2011 Interim results to be reported in the first half of 2012, according to a YM BioSciences media release.
    • 21 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top